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Purpose: This paper analyses what factors determine the demand for vaccination among
the elderly as a high risk group. Using the estimation results, this paper then evaluates
how legal requirements and/or subsidies affect their demand.
Methods: Original data were obtained from two surveys, conducted by the author, given
to two groups: elderly people living with descendants, and elderly people living without
descendants. The surveys contained information about the elderly, the household, experi-
ence of influenza during the last season, immunization during this time, and a hypothetical
questionnaire about immunization for purposes of Conjoint Analysis. Three estimations
are performed for actual behaviour, Conjoint Analysis and Joint Estimation, the latter
combining the first two estimations.
Results: Among estimation results, factors such as cost, number of immunizations, avail-
ability of immunization at night or on the weekend, and legal requirements heavily affect
the demand for immunization. Experience of influenza and immunization in the preceding
season is one of the most important determinants. In addition, the superiority of the Joint
Estimation method is confirmed.
Conclusions: The estimation results imply that about 8.9 million elderly people will have a
demand for vaccination if there is no cost and it is legally recommended. If the cost is 6000
yen (about US$50) and there is no legal recommendation, demand for vaccination will be
reduced to about 3.2 million elderly people. An increase in cost from free vaccination to
just 500 yen (about US$4) depresses demand from 1.6 million elderly people. On its own,
legal recommendations for vaccination can push up demand by 2.0 million elderly persons.
1 Introduction
In Japan, the influenza epidemic of the 1997-98 season was the most severe since influenza
surveillance began in 1987. A total of 136,929 patients were clinically diagnosed with
influenza by sentinel clinics, the highest number ever recorded. There were approximately
50,000 pneumonia and influenza deaths during this season. Each year in the U.S., 10 to
50 million individuals become ill with ‘the flu’. In a typical year, approximately 20,000 of
these individuals die from complications related to the disease.
To assess the severity of influenza epidemics, ‘excess mortality’, the number of deaths
actually recorded in excess of the number expected on the basis of past seasonal experience
has been used as a major index (Serfling (1963), Assad, Cockburn and Sundaresan (1973),
Choi and Thacker (1981) for the US; and Tachibana, Kawaminami and Minowa (1999),
Tachibana and Minowa (1999) for Japan). Shindo, Ii, Ohkusa and Taniguchi (2000) pro-
posed a new method to forecast the expected number of pneumonia and influenza deaths.
According to their method, excess mortality was 5,032 in January 1997, 2,820 in February
1998, and 6,798 in January 1999.
At present, vaccination is considered to be the best measure against influenza. Sev-
eral studies have been conducted on the cost effectiveness of influenza vaccination (Nichol,
Margolis, Wuorena and Sternberg (1994), Gross, Hermogenes, Sacks, Lau and Levandowski
(1995), Levy (1996), Scott and Scott (1996)). Such discussions are useful where vaccina-
tion is compulsory. However, in most industrialized countries, including Japan, this is not
the case. Consequently, it is necessary to investigate what factors determine the demand
for vaccination. This aspect of influenza prevention has attracted little research atten-
tion so far, with the exceptions of Philipson (1996) and Mullahy (1999). Philipson (1996)
examined the demand for measles vaccination using survival analysis to analyse the tim-
ing of vaccination, both during the epidemic and non-epidemic seasons. Mullahy (1999)
estimated the demand for influenza immunization and the labour supply simultaneously,
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and showed that during the influenza outbreak of 1998, the probability of receiving immu-
nization increased according to the level of education, insurance, and higher opportunity
cost. However, Mullahy’s use of a linear probability model and the applicability of the
simultaneous estimation method are questionable.
The demand for influenza vaccination amongst adults less than 70 years old has al-
ready been investigated in Japan12). In that study, two approaches, analysis for the actual
behaviour and conjoint analysis, were employed. In the actual behaviour analysis, past
experience of influenza and the history of vaccination during the 1999-2000 season were
found to be influential in the decision to be vaccinated. In the Conjoint Analysis, it was
found that if the present vaccination fee of 6000 yen were to be waived, demand for vacci-
nation would increase by 8.7 percentage points. If vaccination were provided at night and
during weekends demand would increase by 2.1 percentage points, and if provided as well
at workplaces and schools, it would increase by 3.2 percentage points.
The news of an influenza outbreak was also found to increase the demand for vaccination
by 6.6 percentage points. Higher income, however, was found to reduce the demand for
vaccination. This suggests that opportunity costs may be an influential factor in individ-
uals’ decisions on vaccination. Habit formation, revealed in vaccination history, also plays
a quite important role in the demand for vaccination.
This paper extends the approach of the above study to the elderly, a high-risk group for
influenza. Initially, the survey was completed separately by two groups, elderly people living
with descendants, and elderly people living not living with their descendants. In particular,
for elderly persons living with descendants, the hypothetical questionnaire for conjoint
analysis was answered by their descendants or family. Hospital patients and nursing home
residents were excluded by the purpose of this paper. Following completion of the surveys,
actual behaviour, Conjoint Analysis, and Joint Estimation tests were performed. Joint




This paper is based on data from two separate surveys: elderly people living with descen-
dants, and elderly people not living with their descendants.
2.1 Data for Elderly People with Descendants
The data for elderly people living with descendants was obtained from a survey conducted
in May, 2001 in the Kanto (Tokyo, Kanagawa, Saitama, and Chiba prefectures) in east-
ern Japan, and the Kansai areas (Osaka, Kyoto, Nara, and Hyogo prefectures) in western
Japan. Of a total of 1300 questionnaires distributed, 1024 were completed and returned.
All these households voluntarily contracted with the survey firm to co-operate on various
surveys. The households that were surveyed are randomly sampled by a two-step strata,
but the decision to co-operate is, of course, not random. Therefore, particular attention
should be paid to the sampling bias caused by this type of sampling. As no unemployed
people and few self-employed responded to the survey, there is a small bias to richer house-
holds. However, these biases would be controlled by using such information as explanatory
variables in the estimation rather than making simple comparisons about the average.
This sample contains 265 households and 338 elderly people. The questionnaire asks
about age, gender, chronic illness, household income, assets, home ownership, history of
vaccination, and experience of influenza during the last two seasons. In addition, it asks
hypothetical questions about vaccination which were used in the conjoint analysis. Though
hypothetical questions are completed by members of the elderly person’s family, such as
their descendants or housewives, they should reflect the elderly person’s opinion.
2.2 Data for Elderly People Not Living With Their Descen-
dants
The data for elderly people not living with their descendants were obtained from a survey
conducted in June, 2001, covering the whole of Japan. Of the total 800 questionnaires
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distributed, 737 were completed and returned. These elderly people also voluntarily con-
tracted with the survey firm to co-operate on various surveys. It should be noted that there
is a sampling bias towards healthier elderly people, despite the fact that they are chosen
randomly. Moreover, the sampling rate for more than 70 elderly persons or living in the
rural area because they should be very few in the case of constant sampling rate. Of course,
these unequal sampling rates should be taken into account in the summary statistics or
estimation. While largely identical information is collected in the two surveys from the two
types of households, the complexity of the questionnaire is reduced for elderly people not
living with their descendants.
3 Summary Statistics
Table 1 summarizes the summary statistics for both types of households: the sample size is
338 in the group of elderly people with descendants, and 668 in the group of elderly people
not living with their descendants . The vaccination rates in the ’99/’00 season and ’00/’01
season are 7.5% and 16.1%, respectively. The percentage rates for experiencing influenza,
based on self-assessment, are 15.2
The significant difference in the experience rates of influenza based on each definition
cannot be found. Needless to say, this difference is partly due to the endogenous choice
made about whether to be vaccinated or not. Consequently, there is a selection bias which
contaminates the true efficacy of the data.
In the group of elderly people living with their descendants, vaccination rates and the
experience rate are almost the same. However, the experience rate for this group in the
’99/’00 season based on a doctor’s diagnosis is only 3.0%, which is about half of the experi-
ence rate for elderly persons not living with their descendants. The outbreak of influenza in
that year emphasizes the difference between the two types of households. Of course, elderly
people make an endogenous choice whether or not to live with their descendants. Conse-
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quently, simple comparison of the two types of households is meaningless because there is a
selection bias. However, to analyse this selection, information about the descendants who
live with the elderly people is required. Unfortunately, the collection of such information is
very difficult and there are very few studies that examine this selection process explicitly.
On the other hand, many research studies ignore that bias15,16,17). Consequently, this paper
does not deal with this selection process: that is, the decision whether or not to live with
their descendants is considered to be exogenous, at least for the vaccination decision.
Tables 2 and 3 contain the simple average of the responses to the hypothetical questions.
Note that the figure in Table 2, which represents the responses of elderly people living
with their descendants, is not adjusted for the omitted attributes and thus is somewhat
misleading. Conversely, Table 3, which represents the responses of elderly people not living
with their descendants, contains all the information from the hypothetical questionnaires.
While the questionnaires are different for the two types of household, free vaccination
increases the demand by 5-10 times and it reaches about almost half. It is interesting
that the demand for vaccination is higher when it costs 500 yen (about US$4), than in
the case of free vaccination in the households not living with descendants. The effect of a
legal recommendation to be vaccinated is surveyed only in the case of elderly people not
living with their descendants. It increases the demand for vaccination by 20% points when
vaccination is free, but it has no substantial effect when vaccination costs 2000 yen (about
$16).
4 Analysis of Actual Demand
The dependent variable takes two values: Ji = 1 if a person i received, Ji = 0 if they
did not. The independent variables are Spline function of Age f(Ai), Gender (Gi = 1 if
female, Gi = 0 if male), dummy variable Ci taking the value of one if a person has a history
of chronic illness, household income (in logarithm) Hi, household net financial asset Ni,
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dummy variable M1i taking the value of one if a person owns a house, dummy variable M
2
i
taking the value of one if a person owns an apartment, a dummy variable Fi taking the
value of one if a person suffered from influenza during the last season, and finally a dummy
variable Wi taking the value of one if a person received vaccination during the last season.
Empirical specifications are as follows:
J∗i = α0 + αAf(Ai) + αGGi + αHHi + αCCi
+ αNNi + αM1M 1i + αM2M 2i + αFFi + αWWi + εi　
Ji =
(
1 if J∗i > 0
0 otherwise
(1)
For the purpose of estimation, the probit method with heteroscedasticity consistent is
adopted. The results of the estimation are presented in Table 4.
Though there are not so many significant variables in this table, vaccination in the last
season is significant in both types of households. These marginal effects are very high at
76-83% points. The experience of influenza in the last season is significant in elderly people
living with descendants and it rises 25% points. It is not significant in the group of elderly
people not living with their descendants. Almost all other variables like age or chronic
illness. On average, after taking into account other characteristics, the vaccination rate
of elderly couples is 8.5%points less than for single elderly people, even in the group not
living with their descendants.
5 Conjoint Analysis
5.1 A Brief Explanation of Conjoint Analysis
This study utilizes a technique called Conjoint Analysis, which attempts to elicit people’s
preference for programme benefits. In different hypothetical situations, respondents are
given various options and select their most preferred choice. Conjoint Analysis uses various
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hypothetical situations and individual characteristics as independent variables, and choices
as dependent variables to estimate the statistical model. In addition, Conjoint Analysis
measures the change in utility.
In seeking measures of preference in the hypothetical contexts, approaches that have
commonly been used in health care include standard gamble and time trade-off. These
techniques tend to concentrate on obtaining preference values for health conditions, which
are then used as weights for the adjustment of life years in the calculation of quality-
adjusted life years (QALYs). In addition, willingness-to-pay techniques have also been
used to obtain monetary valuations for programme benefits in the hypothetical context in
health care. Conjoint Analysis, which uses peoples’ statements of how they would respond
to different hypothetical situations, is an alternative approach to obtaining preferences for
programme benefits. Such methods are increasingly being adopted in the health care sector.
Most studies pose questions on opinions on the introduction of new medical technologies,
such as in-vitro fertilization (Ryan (1999)), orthodontic services (Farrar and Ryan (1999)),
abortion technology (Ryan and Hughes(1997)), blood transfusion (Van der Pol and Cairns
(1997)) and the use of MRI for the investigation of knee injuries (Bryan et al. (1998)). In
Japan, however, very few studies have employed the Conjoint Analysis method (Ohkusa
(2000)).
Although Conjoint Analysis may be a better method than the conventional ones, there
remains a possibility of bias arising from two sources: hypothetical choice and hypothetical
scenarios. Ohkusa (2000) shows that both biases are fairly significant, particularly the
conspicuous bias arising from the hypothetical scenarios. The analysis of these biases and
the method of controlling them is an important issue in future research.
For Conjoint Analysis, a probit estimation method with random effect is used. Since the
dependent variable takes the value of one or zero, probit estimation is a basic method. The
random effects approach was chosen as it treats the individual effects as being uncorrelated
with other independent variables, and allows adjustment for the panel nature of the data.
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For Conjoint Analysis, different questionnaires were adopted for elderly people living
with their descendants and for elderly people not living with their descendants. In the
surveys of elderly people living with their descendants, there are four attributes, which are
set as number of times immunized, cost, prevalence, and convenience, which refers to when
and where it is possible to be immunized. In addition, there are two to four conditions
attach ed to each attribution. These include:
Times: once or twice
Cost: free, 1500 yen (about US$12) per shot, or 3000 yen (about US$24) per shot
P r evalen ce: yes o r n o
Accessibili ty : vaccination at the m edical institut ion duri ng t he day t ime, va ccination at t he medical
institution a t n ight or during the weekend, vaccination at an accessible p lace other
than a medical institution, or vaccination at home.
Consequently, there are 48 hypothetical cases. Each respondent is asked 10 cases, in which
there are 5 patterns, and thus in total 50 cases are covered.
On the other hand, for elderly persons not living with their descendants, the hypothetical
questions include would you like to receive an influenza vaccination if
Scenario 1: The law recommends i mmu nization and the cost is 5000 ye n (ab out U S$40)
Scenario 2: The law recommends i mmu nization and the cost is 2000 ye n (ab out U S$16)
Scenario 3: The law recommends i mmu nization and t he cost is 500 yen (ab out US$4)
Scenario 4: The law recommends i mmu nization and it is f ree
Scenario 5: The law do es not recommend immu nization and the co st is 5000 yen (ab out US$40)
Scenario 6: The law do es not recommend immu nization and the co st is 2000 yen (ab out US$16)
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Scenario 7: The law do es not r ecommend i mmu nizati on and t he cost is 500 yen (ab out US$4)
Scenario 8: The law do es not r ecommend i mmu nizati on and t he cost is free
At present the cost is about 3000 yen (about US$24 dollars) per shot, one shot is required
which can be received from a medical institution during the daytime, though there is
no legal recommendation to be immunized. Whether influenza is prevalent or not is a
subjective question to the respondent. In the last season, it was seen to be of moderate
prevalence.
5.2 Estimation using Conjoint Analysis
The dependent variable takes two values: Ji,j. under the jth hypothetical situation. The
independent variables are the variables in addition to those used in equation (1), prices Pi
under hypothetical situations (in logarithm), a dummy variable R1j which takes the value
of one if vaccination is available anytime, a dummy variable R2j which takes the value of
one if vaccination is available at an accessible place, R3j which takes the value of one if
vaccination is available at home, a dummy variable Kj which takes the value of one if
influenza is prevalent, and finally, Lj which takes the value of one if the law recommends
immunization.
Consequently, the empirical specification is
J∗i,j = βi + βP logPj + βR1R1j + βR2R2j + βR3R3j + βKKj + βLLj　
+ βAf(Ai) + βGGi + βHHi + βNNi





1 if J∗i,j > 0
0 otherwise
(2)
where βi is a random variable following N(0,σ2β) and represents the individual effect. For
estimation, the probit method with random effect is used. With 10/8 hypothetical situa-
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tions, the maximum size of j is 10/8, although some did not answer all questions. Therefore,
we were not able to observe 18 samples for each respondent. Estimation results are shown
in Table 5.
The cost is significantly negative. When the cost is reduced from the current level of 6000
yen (about $24) in two shots, and made free of charge, the vaccination rate would increase
by 22-32% points. If the number of shots required is reduced from two to one, vaccination
rates rise by 14% points. If vaccination is available at any time, the rate wouldincrease
by 34% points, but vaccination at an accessible place or at home does not contribute to
an increase in the vaccination rate. Prevalence does not influence the rate. On the other
hand, if the law enforces immunization it increases by 9.5% points.
In other variables under the hypothetical question, the vaccination and experience of
influenza in the last season are positive and significant, as in Table 4. Moreover, the
marginal effect of the vaccination in the last season reached 43-62% points. The experience
of influenza in the last season is significant and its marginal effect is about 12%points.
However, it is not significant amongst elderly people living with their descendants.
6 Analysis using Joint Estimation
So far, the actual behaviour and conjoint analysis have been estimated separately, but
these two data set have advantages and disadvantages. For example, although the actual
behaviour is objective and amenable to analysis, it does not contain information about the
effect of cost or other policy variables. In addition, it cannot be determined which individual
effect would be the most important determinant of the behaviour. Joint estimation13,14) is
proposed to overcome the problems of using these two approaches. Specifically, on the one
hand, joint estimation uses the same coefficients on the common variables as the other two
approaches, such as age, gender and chronic illness, and on the other hand, it estimates
the effect of the hypothetical situation. In this way, it excludes extreme responses to the
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hypothetical situation and thus provides a more reliable estimator for cost and/or other
policy variables. The estimation equation is as follows:
J∗i,j,k = γi + γP logPj + γR1R1j + γR2R2j + γR3R3j + γKKj + γLLj　
+ γAf(Ai) + γGGi + γHHi + γNNi
+ γCCi + γM1M1i + γM2M2i + γWWi + γFFi + γEEi + γCJCJk + εi,j,k　
Ji,jk =
(
1 if J∗i,j,k > 0
0 otherwise
(3)
where k denotes whether this data comes from actual behaviour or Conjoint Analysis, and
CJk is the dummy variable for Conjoint Analysis data. γi is a random effect like βi in
Eq.(2), but is also included even in the actual behaviour data.
The estimation results are summarized in Table 6. This shows that the estimators for
hypothetical situations like cost are almost the same as in Table 5. In this sense, the
estimates provided by Conjoint Analysis are as reliable as the Joint Estimation, at least in
this estimation.
Under Joint Estimation, the effect of vaccination in the last season decreases to 37-
22% points, which is the lowest in the three estimation procedures. The past experience
of influenza is significant for both types of households and its impact is 12-19% points.
This figure is close to the actual behaviour estimate for elderly persons living with their
descendants, and, conversely, it is close to the Conjoint Analysis estimate for elderly persons
not living with their descendants. Thus, the figure shows how the Joint Estimation method
avoids the extreme estimator.
In regard to chronic illness, the number of significant coefficients in Joint estimation is
the highest of the three estimations. Cardiovascular disease is significant and positive in
elderly people living with their descendants, and nervous, sensorium, and other chronic
illness are significant in elderly people not living with their descendants. This finding also
indicates the advantages of Joint estimation, as these are not significant in the estimation
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in the actual behaviour or Conjoint Analysis. In Need for Assistance increases the rate by
11%points, which is the same in Table 5.
7 Pooling Estimation for Both Types of Household
In addition, Joint estimation is applied to the pooled data for both household types. We
can discuss household types and demand forecasts via this method of pooling
Let t be the subscription for the household type. Then the estimation equation is:
J∗i,j,k,t = ηi + ηP logPj + ηR1R1j + ηR2R2j + ηR3R3j + ηKKj + ηLLj　
+ ηAf(Ai) + ηGGi + ηHHi + ηNNi
+ ηCCi + ηM1M1i + ηM2M2i + ηWWi + ηFFi + ηEEi + ηCCk　
+ ηAf(Ai) + ηGGi + ηHHi + ηNNi




1 if J∗i,j,k,t > 0
0 otherwise
(4)
where Zt is the dummy variable for elderly people not living with their descendants. This
specification means that the coefficients of the hypothetical situation, other than cost, are
assumed to be the same among the type of households, while cost and other characteristics
of households or elderly persons can differ. Estimation results are summarized in Table
7. Note that the number in the column labelled ”elderly persons not living with their
descendants” does not have the same meaning as in other tables and indicates the difference
between the coefficients of elderly people not living with their descendants and those of
elderly people living with their descendants.
Table 7 shows that cost is more inelastic, i.e. its marginal effect is -0.022 for elderly
persons not living with their descendants, and -0.036 for elderly persons living with their
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descendants. Other coefficients are very similar to the non-pooled estimations. For exam-
ple, although the dummy variable for household types is not significant, there are significant
differences among types in chronic illness as with the Conjoint dummy variable. In partic-
ular, as in Table 6, elderly persons not living with their descendants showed a smaller gap
between actual behaviour and Conjoint Analysis than for elderly persons living with their
descendants.
8 Simulation for Vaccination Demand
Finally, we attempt to simulate and forecast the vaccination demand. Incidentally, in 1998
there were 20.62 million elderly persons over 65 years of age, of which 11.22 million lived
with their descendants and 9.39 million did not live with their descendants.
Since there are many policy variables in the hypothetical questionnaire, to avoid an
overly complex presentation, the simulation relates only to the two factors which most
concern policy: the cost of vaccination, and whether or not it is a legal requirement. Other
factors in the hypothetical situations are assumed to remain constant - it is assumed that
only one shot is necessary, which is given at a medical institution during the daytime, and
that there is no prevalence. These assumptions basically represent the current situation.
Other variables outside the hypothetical situation, such as age, gender and chronic illness,
are assumed to obey the actual distribution of the sample data, which means it is assumed
that the sample distribution is representative.
Simulation results are summarized in Table 8 with a 90% confidence interval. The table
shows that when cost is 6000 yen (about $48 dollars) and there is no legal recommendation
for vaccination, the number of elderly persons who were immunized is the lowest, 3.22
million. This is believed to be the current situation. When vaccination is free of charge and
recommended by the law, the number of elderly persons vaccinated increases dramatically
to 8.93 million, or about 40% of elderly persons.
13
However, when the cost increases to 500 yen (about $4), 1.6 million elderly persons are
discouraged from immunization. On the other hand, if vaccination is recommended by law,
even if the cost is not reduced, 2 million elderly persons are encouraged to be immunized.
9 Concluding Remarks
This paper examines the demand for influenza vaccination in Japan by elderly persons,
which are a high-risk group. Original data were obtained from a survey conducted by the
author. Three approaches, actual behaviour, conjoint analysis, and joint estimation, which
combines the first two approaches, were employed. The results provide many interesting
points and reliable policy recommendations.
However, some remarks should be noted on interpretation of the data. First, the research
basis of the survey may be contaminated by the sampling bias. In particular, it does not
survey inpatients and residents in institutions. In addition, even if they live at home, weak
and unhealthy elderly persons may not have been included in the survey. In general, it is
not well known whether this group is likely to be immunized or whether their demand for
vaccination has a low price elasticity. To answer this problem, the survey should be extend
to this group, but a mailing survey may not be appropriate for this purpose.
Secondly, even if joint estimation techniques are adopted, which can exclude extreme
responses to hypothetical situations, it is not clear how these could be successfully utilised.
A gap may remain between actual behaviour and the hypothetical situation. This can only
be resolved by conducting further surveys and analysis, which will provide more reliable
estimators. There remains a need for further research.
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Self Assessment(’99/’00) .1615854 .1525926
Self Assessment(’00/’01) .1397516 .1101322
Diagnosis(’99/’00) .0304878 .0681481
Diagnosis(’00/’01) .0310559 .0368189
Age 　　 71.10853 70.15875
Female dummy .4571429 .4966079
Respiratory Chronic Illness .121447 .0556309
Digestive Chronic Illness .1111111 .1451832
Cardiovascular Chronic Illness .3333333 .256445
Nervous Chronic Illness .0981912 .0257802
Muscular and Skeletal Chronic Illness .3436693 .1478969
Unitary Chronic Illness .0723514 .0597015
Endocrine Chronic Illness .2609819 .202171
Sensorium Chronic Illness .2325581 .2035278
Other Chronic Illness .3229974 .0257802
In Need for Assistance　　　 .0502035
Household Income (in log) 5.99161 5.121297
Net Financial Asset 676.615 1412.687
Real Asset (Home) .8191214 .8276798
Real Asset (Apartment) .0930233 .0759837
Single Elderly Person 　　　　
Elderly Couples .8680556
Elderly persons with Descendants 1 .0208333
Other Household .0083333
Big City .3747 .2551
Medium City .0310 .1493
Small City .5504 .4518
Rural .0439 .1343
Farm Village 　 .0095
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　Table 2: Conjoint Analysis of Vaccination for Elderly Persons Living
















At Home 　　 .375
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　Table 3: Conjoint Analysis of Vaccination for Elderly Persons Not
Living with Descendants
Legal recommendation Cost (Yen)　 Vaccination
Rate









　Table 4: Estimation Results for Actual Behaviour









Age 　　 .0067135 0.562 .0101318 0.240
(Age - 70)1[Age ≥ 70] -.0170941 0.469 -.013802 0.367
(Age - 75)1[Age ≥ 75] .0009228 0.978 .0183957 0.363
(Age - 80)1[Age ≥ 80] .0123913 0.769 -.01073241 0.592
(Age - 85)1[Age ≥ 85] -.0322048 0.463 -.01073241 0.592
Female du1[Age ≥ 90] -.0027124 0.937 .0366968 0.191
Respiratory Chronic Illness -.0435962 0.440 .037826 0.476
Digestive Chronic Illness -.0059544 0.913 .0035925 0.916
Cardiovascular Chronic Illness .0446591 0.255 .0519703 0.102
Nervous Chronic Illness -.0131215 0.793 .0374057 0.680
Muscular and Skeletal Chronic Illness -.0109033 0.767 .044014 0.223
Unitary Chronic Illness .0471642 0.451 .0884861 0.108
Endocrine Chronic Illness -.0153965 0.692 .0998169 0.003
Sensorium Chronic Illness -.0344334 0.447 .0073932 0.810
Other Chronic Illness .0004998 0.990 -.067304 0.079
In Need for Assistance -.0076047 0.907
Influenza Experience .2780875 0.000 .0364175 0.357
Vaccination Experience .7553172 0.000 .8339464 0.000
Household Income (in log) .0043047 0.593 -.0037152 0.682
Net Financial Asset -2.02e-06 0.846 -9.50e-06 0.273
Real Asset (Home) .0788892 0.131 .016572 0.706
Real Asset (Apartment) .052781 0.639 .1109919 0.136
Elderly Couples -.0851013 0.070
Elderly persons with Descendants .0346669 0.688
Medium City .0357897 0.692 -.0203777 0.564
Small City .0058377 0.880 -.0127894 0.675
Rural .0173722 0.684
Note: The likelihood ratio test for all coefficients except for the constant term which is zero
for elderly persons living with their descendants are rejected at 1% significance level. Its log
likelihood is -82.791 and pseudo R2 is 0.3031. The likelihood ratio test for all coefficients
except for the constant term which is zero for elderly persons not living with descendants
are rejected at 1% significance level. Its log likelihood is -151.54 and pseudo R2 is 0.3657.
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　Table 5: Estimation Results for Conjoint Analysis









Cost(in log) -.02522089 0.000 -.03677605 0.000
Two Shots Dummy 　 -.14276516 0.000
Shot at Night or Weekend Dummy .34337536 0.000
Shot at Accessible Place .00893647 0.814
Shot at Home -.04432643 0.224
Prevalence Dummy　　　 　 .00534984 0.891
Legal Recommendation 　　　 .09498724 0.000
Age 　　 .0362586 0.164 .00082562 0.940
(Age - 70)1[Age ≥ 70] -.0103762 0.604
(Age - 75)1[Age ≥ 75] -.07922911 0.091 .01283505 0.674
(Age - 80)1[Age ≥ 80] .04564262 0.387 .02290995 0.637
(Age - 85)1[Age ≥ 85] .06334376 0.317
(Age - 90)1[Age ≥ 90] -.08105918 0.261
Female dummy -.00112939 0.990 .0303149 0.345
Respiratory Chronic Illness -.09629074 0.452 -.11666444 0.063
Digestive Chronic Illness -.07912406 0.391 .02229562 0.627
Cardiovascular Chronic Illness .06743487 0.306 .00888117 0.796
Nervous Chronic Illness -.10955807 0.150 .27131134 0.034
Muscular and Skeletal Chronic Illness .11335961 0.148 -.00771539 0.855
Unitary Chronic Illness .07793709 0.422 .06497005 0.308
Endocrine Chronic Illness .02870001 0.711 .00743586 0.846
Sensorium Chronic Illness -.11174018 0.150 .05051267 0.210
Other Chronic Illness -.04287212 0.561 .19054796 0.176
In Need for Assistance .11989901 0.098
Influenza Experience .01551211 0.885 .11571933 0.005
Vaccination Experience .61963421 0.000 .43626562 0.000
Household Income (in log) .0066106 0.714 -.00585357 0.647
Net Financial Asset .00001227 0.505 .00001175 0.294
Real Asset (Home) -.12492886 0.332 -.08429571 0.136
Real Asset (Apartment) -.00025391 0.999 -.10049675 0.180
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Elderly Couples -.00468678 0.931
Elderly persons with Descendants . .03410025 0.780
Other Household -.16169356 0.402
Medium City .15525582 0.437 .03815038 0.465
Small City .06028977 0.372 .06095812 0.118
Rural .35386404 0.049 .01307271 0.813
Farm Village -.04240934 0.601
Note: The sample size of elderly persons living with their descendants is 144 individuals
and 1283 samples. The likelihood ratio test for all coefficients except for the constant
term is zero in this case. The sample size of the group of elderly persons not living with
their descendants is 700 individuals and 2557 samples. The likelihood ratio test for all
coefficients, except for the constant term which is zero, is rejected at 1% significance level.
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　Table 6: Joint Estimation among Actual Behaviour and Conjoint
Analysis









Cost(in log) 　 -.02438339 0.000 -.03589957 0.000
Two Shots Dummy 　 -.13432005 0.000
Shot at Night or Weekend Dummy .33165383 0.000
Shot at Accessibility Place .01282752 0.723
Shot at Home -.03727379 0.276
Prevalence Dummy　　　 　 .00990128 0.786
Law Recommendation 　　　 .09475876 0.000
Age 　　 .0075168 0.736 .00230228 0.812
(Age - 70)1[Age ≥ 70] .01453093 0.699 -.00958017 0.596
(Age - 75)1[Age ≥ 75] -.05203914 0.204 .01699283 0.538
(Age - 80)1[Age ≥ 80] .0160218 0.754 -.02005843 0.615
(Age - 85)1[Age ≥ 85] .05284339 0.391
(Age - 90)1[Age ≥ 90] -.05539586 0.402
Female dummy .06417374 0.290 -.00828369 0.778
Respiratory Chronic Illness -.09595305 0.313 -.05999469 0.335
Digestive Chronic Illness -.09708313 0.252 .01960893 0.637
Cardiovascular Chronic Illness .08529077 0.097 .03668624 0.251
Nervous Chronic Illness -.07076987 0.349 .27624604 0.000
Muscular and Skeletal Chronic Illness .08061989 0.173 -.01111679 0.780
Unitary Chronic Illness .146584 0.114 .08578814 0.127
Endocrine Chronic Illness .04467399 0.441 .04232854 0.228
Sensorium Chronic Illness -.04014177 0.522 .06506282 0.069
Other Chronic Illness -.0361404 0.540 .15032881 0.069
In Need for Assistance .1095157 0.070
Influenza Experience .16867374 0.017 .12428474 0.000
Vaccination Experience .36870903 0.000 .22118837 0.000
Household Income (in log) .00474678 0.755 -.005132 0.658
Net Financial Asset 7.209e-06 0.633 6.338e-06 0.534
Real Asset (Home) -.0370723 0.702 -.07369098 0.149
Real Asset (Apartment) -.06185246 0.624 -.06226342 0.365
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Elderly Couples -.02452867 0.629
Elderly persons with Descendants .03124743 0.794
Other Household -.22222303 0.282
Medium City .0886554 0.565 .02670482 0.575
Small City .03478028 0.538 .05346023 0.134
Rural .15519883 0.250 .0080299 0.868
Farm Village -.0707356 0.301
Conjoint Dummy .27317652 0.000 .5945397 0.000
Note: The sample size of elderly persons living with descendants is 328 individuals and
1590 samples. The likelihood ratio test for all coefficients except for the constant term
is zero in this case. The sample size of elderly persons not living with descendants is
718 individuals and 3185 samples and its likelihood ratio test for all coefficient except for
constant term is zero for the elderly persons living without descendants are rejected at 1%
significant level.
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　Table 7: Joint Estimation on the Pooled among Household Types









Cost (in log) 　 -.02255168 0.000 -.01409002 0.003
Two Shots Dummy 　 -.12342393 0.000
Shot at Night or Weekend Dummy .30599144 0.000
Shot at Accessibility Place .01249799 0.708
Shot at Home -.0340722 0.282
Prevalence Dummy　　　 　 .00967683 0.774
Legal Recommendation 　　　 .09732786 0.000
Age 　　 .00797087 0.703 -.00592108 0.797
(Age - 70)1[Age ≥ 70] .01254973 0.722 -.0220246 0.579
(Age - 75)1[Age ≥ 75] -.0488111 0.206 .06603176 0.165
(Age - 80)1[Age ≥ 80] .01444977 0.765 -.03394031 0.590
(Age - 85)1[Age ≥ 85] .05020476 0.390
(Age - 90)1[Age ≥ 90] -.05156333 0.408
Female dummy .0656891 0.245 -.07540935 0.238
Respiratory Chronic Illness -.08603337 0.334 .02372582 0.827
Digestive Chronic Illness -.09906714 0.220 .11901429 0.191
Cardiovascular Chronic Illness .07969082 0.101 -.04231704 0.468
Nervous Chronic Illness -.06638294 0.359 .34596825 0.001
Muscular and Skeletal Chronic Illness .07496171 0.178 -.08564496 0.212
Unitary Chronic Illness .14671101 0.098 -.05977958 0.570
Endocrine Chronic Illness .04251697 0.436 -.00063726 0.992
Sensorium Chronic Illness -.03192429 0.589 .09709249 0.161
Other Chronic Illness -.03353948 0.548 .18539838 0.069
In Need for Assistance .11277641 0.064
Influenza Experience .30999771 0.001 -.04607038 0.648
Vaccination Experience .16526113 0.013 -.04014137 0.593
Household Income (in log) .00451159 0.755 -.00986377 0.596
Net Financial Asset 5.266e-06 0.710 1.557e-06 0.929
Real Asset (Home) -.03900807 0.673 -.03267661 0.758
Real Asset (Apartment) -.07345112 0.535 .0116132 0.933
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Elderly Couples -.02373158 0.643
Elderly persons with Descendants .58472371 0.709 .03512046 0.772
Other Household -.22844841 0.275
Medium City .08098421 0.574 -.05477642 0.718
Small City .02960441 0.578 .0238345 0.711
Rural .13517834 0.290 -.12904885 0.346
Farm Village -.06888663 0.314
Conjoint Dummy .25660342 0.000 .34807029 0.000
Note: The sample size is 1046 individuals and 4775 samples. The likelihood ratio test for
all coefficient except for the constant term are zero.
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　Table 8: Forecast for Demand of Vaccination and its 95%CI (Million
Elderly Persons)










Free 2.687 3.006 3.344 3.617 3.985 4.366
500 1.472 2.005 2.274 2.134 2.803 3.129
1000 1.366 1.909 2.169 1.996 2.684 3.003
1500 1.307 1.854 2.110 1.919 2.616 2.931
2000 1.265 1.816 2.068 1.865 2.569 2.880
2500 1.234 1.786 2.036 1.824 2.532 2.841
3000 1.209 1.763 2.010 1.791 2.503 2.809
3500 1.188 1.743 1.989 1.763 2.478 2.783
4000 1.170 1.726 1.970 1.739 2.456 2.760
4500 1.155 1.711 1.953 1.719 2.437 2.739
5000 1.141 1.697 1.939 1.700 2.421 2.721
5500 1.129 1.685 1.926 1.684 2.405 2.705
6000 1.117 1.675 1.914 1.669 2.392 2.690
Living without Descendants
Free 3.624 3.967 4.318 4.592 4.947 5.301
500 1.589 2.113 2.386 2.277 2.913 3.231
1000 1.421 1.943 2.203 2.065 2.710 3.018
1500 1.328 1.847 2.100 1.946 2.594 2.897
2000 1.265 1.781 2.028 1.865 2.514 2.812
2500 1.218 1.731 1.974 1.803 2.452 2.747
3000 1.180 1.691 1.930 1.754 2.402 2.694
3500 1.148 1.657 1.893 1.713 2.361 2.650
4000 1.122 1.628 1.862 1.678 2.325 2.612
4500 1.099 1.603 1.835 1.647 2.294 2.579
5000 1.078 1.581 1.811 1.620 2.266 2.549
5500 1.060 1.561 1.789 1.596 2.241 2.523
6000 1.043 1.543 1.769 1.574 2.219 2.499
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